Greenwich Wealth Management’s GSK GSK Stock Holding History

Greenwich Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.76M	Sell	31,883 -18	-0.1%	-$975	0.07%	124
2025 Q4	$1.56M	Buy	31,901 +1	+0%	+$47	0.07%	130
2025 Q3	$1.38M	Buy	31,900 +1	+0%	+$39	0.07%	128
2025 Q2	$1.23M	Hold	31,899	–	–	0.06%	119
2025 Q1	$1.24M	Sell	31,899 -1,037	-3%	-$38K	0.09%	107
2024 Q4	$1.11M	Buy	32,936 +888	+3%	+$32K	0.08%	114
2024 Q3	$1.31M	Buy	32,048 +1	+0%	+$41	0.09%	101
2024 Q2	$1.23M	Sell	32,047 -50	-0.2%	-$2.1K	0.09%	103
2024 Q1	$1.38M	Hold	32,097	–	–	0.11%	93
2023 Q4	$1.19M	Sell	32,097 -100	-0.3%	-$3.59K	0.12%	95
2023 Q3	$1.17M	Sell	32,197 -19	-0.1%	-$674	0.12%	93
2023 Q2	$1.15M	Hold	32,216	–	–	0.12%	98
2023 Q1	$1.15M	Sell	32,216 -24	-0.1%	-$840	0.13%	99
2022 Q4	$1.13M	Hold	32,240	–	–	0.12%	101
2022 Q3	$949K	Sell	32,240 -162	-0.5%	-$6.14K	0.1%	108
2022 Q2	$1.76M	Hold	32,402	–	–	0.23%	76
2022 Q1	$1.76M	Sell	32,402 -88	-0.3%	-$4.78K	0.18%	82
2021 Q4	$1.79M	Hold	32,490	–	–	0.15%	80
2021 Q3	$1.55M	Buy	32,490 +448	+1%	+$22.5K	0.13%	83
2021 Q2	$1.59M	Hold	32,042	–	–	0.14%	81
2021 Q1	$1.43M	Hold	32,042	–	–	0.11%	85
2020 Q4	$1.47M	Sell	32,042 -560	-2%	-$25.7K	0.13%	78
2020 Q3	$1.53M	Hold	32,602	–	–	0.27%	66
2020 Q2	$1.66M	Sell	32,602 -1,600	-5%	-$82.1K	0.32%	61
2020 Q1	$1.62M	Sell	34,202 -640	-2%	-$34.1K	0.35%	54
2019 Q4	$2.05M	Hold	34,842	–	–	0.41%	53
2019 Q3	$1.86M	Buy	34,842 +458	+1%	+$23.6K	0.36%	55
2019 Q2	$1.72M	Buy	34,384 +400	+1%	+$20.1K	0.3%	58
2019 Q1	$1.77M	Buy	33,984 +22	+0.1%	+$1.1K	0.31%	58
2018 Q4	$1.62M	Sell	33,962 -800	-2%	-$39.4K	0.32%	54
2018 Q3	$1.75M	Sell	34,762 -640	-2%	-$32.5K	0.3%	60
2018 Q2	$1.78M	Hold	35,402	–	–	0.32%	59
2018 Q1	$1.73M	Buy	35,402 +480	+1%	+$22.4K	0.27%	59
2017 Q4	$1.55M	Sell	34,922 -800	-2%	-$37K	0.26%	61
2017 Q3	$1.81M	Sell	35,722 -3,718	-9%	-$189K	0.31%	56
2017 Q2	$2.13M	Sell	39,440 -560	-1%	-$29.9K	0.36%	55
2017 Q1	$2.11M	Sell	40,000 -320	-0.8%	-$16.2K	0.28%	56
2016 Q4	$1.94M	Sell	40,320 -1,040	-3%	-$51.4K	0.25%	59
2016 Q3	$2.23M	Sell	41,360 -320	-0.8%	-$17.5K	0.39%	52
2016 Q2	$2.26M	Hold	41,680	–	–	0.55%	46
2016 Q1	$2.11M	Sell	41,680 -12,517	-23%	-$623K	0.55%	45
2015 Q4	$2.73M	Buy	54,197 +120	+0.2%	+$6.12K	0.67%	41
2015 Q3	$2.6M	Sell	54,077 -53,683	-50%	-$2.79M	0.63%	52
2015 Q2	$5.61M	Buy	+107,760	New	+$6.07M	0.72%	51
2015 Q1	–	Sell	-103,840	Closed	-$5.55M	–	178
2014 Q4	$5.55M	Buy	103,840 +600	+0.6%	+$33.6K	0.37%	61
2014 Q3	$5.93M	Hold	103,240	–	–	0.4%	63
2014 Q2	$6.9M	Hold	103,240	–	–	0.46%	59
2014 Q1	$6.89M	Hold	103,240	–	–	0.48%	56
2013 Q4	$6.89M	Hold	103,240	–	–	0.7%	55
2013 Q3	$6.47M	Buy	103,240 +200	+0.2%	+$12.9K	0.46%	55
2013 Q2	$6.46M	Buy	+103,040	New	+$6.54M	0.48%	57

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Greenwich Wealth Management's GSK Position: Q1 2026 in Review

Greenwich Wealth Management reduced its GSK (GSK) stake by 0.06% in Q1 2026, selling an estimated $975 and leaving 31,883 shares worth $1.76M. The position accounts for 0.07% of the portfolio, ranked #124.

Greenwich Wealth Management first reported a position in GSK in Q2 2013 and has held it in 51 quarters since. The position peaked at $6.9M in Q2 2014. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

Greenwich Wealth Management held 31,883 shares of GSK worth $1.76M as of Q1 2026.
Greenwich Wealth Management sold 18 GSK shares in Q1 2026, an estimated $975.
GSK made up 0.07% of Greenwich Wealth Management's portfolio in Q1 2026, its #124 holding.
Greenwich Wealth Management first reported a position in GSK in Q2 2013 and has held it in 51 quarters since.
Greenwich Wealth Management's GSK position peaked at $6.9M in Q2 2014.
1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Greenwich Wealth Management's 13F filing for Q1 2026, filed 12 May 2026.